Background Ovarian suppression plus tamoxifen is a standard adjuvant treatment in premenopausal women with endocrine-responsive breast cancer.

• 背景：卵巢去势加他莫昔芬是绝经前妇女激素敏感性乳腺癌的标准辅助治疗方案。